Target intelligence / Profile preview

MutS beta complex (MutSβ) (MutSβ)

Target
MutSβ
Molecular classification
DNA mismatch repair protein, ATPase, Heterodimeric protein complex, Enzyme
01

Overview

The MutS beta (MutSβ) complex is a heterodimeric protein assembly consisting of MSH2 and MSH3, which plays a vital role in the eukaryotic DNA mismatch repair (MMR) system (UniProt Consortium, 2023). It specifically recognizes and binds to larger insertion-deletion loops (IDLs) of up to 13 nucleotides, as well as certain base-base mismatches (Iyer et al., 2006). While its canonical function is to maintain genomic stability, MutSβ has been paradoxically implicated in the pathogenesis of trinucleotide repeat expansion disorders, such as Huntington's disease and Myotonic Dystrophy (Flower et al., 2019). In these diseases, the complex binds to CAG/CTG repeat hairpins and promotes somatic expansion, which correlates with earlier disease onset and increased severity (Tabrizi et al., 2020). Because MSH3 is the limiting subunit of the complex and is not essential for all MMR functions, it has emerged as a promising therapeutic target for slowing repeat expansion (Williams et al., 2020). Current drug development efforts focus on using antisense oligonucleotides (ASOs) or small molecules to reduce MSH3 expression or inhibit MutSβ activity (Triplet Therapeutics, 2021). However, a significant therapeutic challenge involves ensuring that the inhibition of MutSβ does not lead to microsatellite instability or an increased risk of cancer due to impaired DNA repair (Schmidt & Pearson, 2016).

Other names
MSH2-MSH3 complexhMutSβMutS-betaDNA mismatch repair protein MutS beta
02

Mechanism of action

Inhibition of MutSβ-mediated recognition and stabilization of DNA loops to prevent somatic expansion of trinucleotide repeats.

03

Biological functions

DNA mismatch repairDNA damage recognitionTrinucleotide repeat expansionGenome maintenance
04

Disease associations

Huntington's diseaseColorectal cancerLynch syndromeSpinocerebellar ataxiaMyotonic dystrophy
05

Safety considerations

Potential for increased microsatellite instabilityRisk of secondary malignanciesImpairment of canonical DNA mismatch repair
06

Interacting drugs

MSH3 antisense oligonucleotides

1 more in the full profile.

07

Biomarkers

MSH3 expression levelsCAG repeat expansion rateMicrosatellite instability (MSI) statusMSH3 polymorphisms (e.g., rs26271)

Beyond the preview

Go deeper on MutS beta complex (MutSβ) (MutSβ).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MutS beta complex (MutSβ) (MutSβ).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call